Yuki Ichihara
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Author Correction: IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice.
Journal: Scientific reports
Published: September 01, 2025
Author Correction: Fibrin Glue-aided, Instant Epicardial Placement Enhances the Efficacy of Mesenchymal Stromal Cell-Based Therapy for Heart Failure.
Journal: Scientific reports
Published: June 25, 2025
Corrigendum to "Self-assembling peptide hydrogel enables instant epicardial coating of the heart with mesenchymal stromal cells for the treatment of heart failure" [Biomaterials 154 (2018) 12-23].
Journal: Biomaterials
Published: February 10, 2024
Corrigendum to "On-site fabrication of bi-layered adhesive mesenchymal stromal cell dressings for the treatment of heart failure" [Biomaterials 209 (2019) 41-53].
Journal: Biomaterials
Published: February 09, 2024
Epicardial placement of human MSC-loaded fibrin sealant films for heart failure: Preclinical efficacy and mechanistic data.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 23, 2023
Epicardial placement of human MSC-loaded fibrin sealant films for heart failure: Preclinical efficacy and mechanistic data.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 02, 2020
Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy.
Journal: Basic research in cardiology
Published: May 20, 2019
Fibrin Glue-aided, Instant Epicardial Placement Enhances the Efficacy of Mesenchymal Stromal Cell-Based Therapy for Heart Failure.
Journal: Scientific reports
Published: March 07, 2018
Self-assembling peptide hydrogel enables instant epicardial coating of the heart with mesenchymal stromal cells for the treatment of heart failure.
Journal: Biomaterials
Published: May 31, 2017
IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice.
Journal: Scientific reports
Published: May 05, 2017
Last Updated: 09/26/2026